Cargando…
Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
Autores principales: | Gao, Yong-Hua, Chen, Rong-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280091/ https://www.ncbi.nlm.nih.gov/pubmed/34250958 http://dx.doi.org/10.1097/CM9.0000000000001340 |
Ejemplares similares
-
Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021) -
Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and
Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020) -
Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017) -
Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018) -
Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: Lipson, David A., et al.
Publicado: (2021)